- Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cellsMichala Jakubíková
Department of Neurology and Clinical Neuroscience Center, 1st Faculty of Medicine of Charles University and General Teaching Hospital in Prague, Czech Republic Electronic address
J Neurol Sci 358:101-6. 2015..Myasthenia gravis (MG) is the autoimmune disorder in which the thymus is considered the pathogenic organ. Thymectomy (TE) is a therapeutic option for MG and often ameliorates clinical symptoms...
- Myasthenia gravis, Castleman disease, pemphigus, and anti-phospholipid syndromeMichala Jakubíková
Department of Neurology and Center of Clinical Neuroscience, Charles University Prague, First Faculty of Medicine and General University Hospital, Prague Kateřinská 30, 128 01 Praha 2, Czech Republic
Muscle Nerve 47:447-51. 2013..Castleman disease is a rare lymphoproliferative disease characterized by non-cancerous angiofolicular hyperplasia of lymphatic tissue...